June 28, 2026 11:04 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Fresh paper leak rocks India: Maharashtra TET postponed a day before exam, over 4 lakh aspirants affected | Pune fort murder case: Siya Goyal's brother says family would have called off marriage if she had objected | Donald Trump gets a road named after him in India, says 'Thank You!' | Fresh setback for Gautam Adani? US judge asks DoJ to justify dropping criminal charges | Ram Mandir Trust chief Champat Rai resigns as alleged donation siphoning row escalates | Ram Mandir fund row deepens: 8 arrested days after BJP called allegations 'false narrative' | 'Who tied the hands of CBI?': Calcutta HC on RG Kar case; victim's mother, now BJP MLA, says she is 'deeply disturbed' | Construction comes to a standstill at nearly 700 Kolkata projects after Taratala warehouse tragedy kills 15 | World Cup shocker! Ecuador stun Germany 2-1, storm into Round of 32 | Iran-US conflict: Cargo vessel hit near Strait of Hormuz, UN agency pauses evacuation operations
Covid-19 Vaccine
Image Credit: Firhad Hakim Twitter

Kolkata: Firhad Hakim gets vaccinated in Covaxin's phase 3 trial

| @indiablooms | Dec 02, 2020, at 11:42 pm

Kolkata/IBNS: Kolkata Municipal Corporation (KMC)'s chairman of board of administrators and West Bengal Minister, Firhad Hakim, on Wednesday got vaccinated in the third phase of trial of India's indigenous vaccine candidate against Covid-19, Covaxin.

The third phase trial was inaugurated in the city by West Bengal Governor Jagdeep Dhankhar at Kolkata's National Institute of Cholera and Enteric Disease (NICED)  on Tuesday.

After getting vaccinated, Hakim, who became the second candidate to take the dose of Covaxin in the trial, said, "I am fully fine after getting vaccinated."

"I don't care even if I die. My vaccination will be fruitful when the entire country will get vaccinated," he said.

A total of 1,000 people will participate in the third phase of the vaccine trial of Covaxin developed by Indian biotechnology company Bharat Biotech.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.